UPC – The Unified Patent Court

The UPC and Unitary Patent will introduce the most radical changes to patent litigation in Europe in 40 years.

The Unified Patent Court (UPC) and the European patent with unitary effect (Unitary Patent) are expected to come into full force at the beginning of 2023. The Unitary Patent is a new, single pan-European right protecting an invention, which prohibits anyone but the owner or their licensees from practising that invention in all of the participating EU Member States.

As Europe’s leading patent law firm, Taylor Wessing has combined its resources from these and other European countries to establish a uniquely adaptable and capable UPC Group to fit exactly the needs of your specific case in the UPC: 

  • Law – we bring knowledge of the key substantive and procedural law traditions that are expected to shape UPC law and practice. 

  • Language – our linguistic skills and the location of our offices ensure that you can be easily represented in the major languages and divisions of the UPC. 

  • Legal skills – our lawyers bring a flexible and complementary mixture of common and civil law experience and skill sets from the above countries, enabling us to deal with all of the 32 opportunities and challenges that the UPC will bring for you.

What is the UPC? Our latest Q&A explains all

In this Q&A, we answer your questions regarding the UPC, helping you to assess whether the UPC system will be beneficial or risky for your company and IP assets. The original version of the Q&A first appeared in GTDT Lexology in April 2021 and can be accessed here.

Read more

Latest UPC insights

UPC

Major European patent law publishing project ahead of the Unified Patent Court led by our specialists

26 septembre 2022

par Dr Paul England

Cliquer ici pour en savoir plus
UPC

The challenging timeline of patent infringement proceedings before the Unified Patent Court

23 septembre 2022
Briefing

par plusieurs auteurs

Cliquer ici pour en savoir plus
UPC

What is new on preliminary injunction proceedings in pharma and biotech cases in Germany – and would it be different under the UPC?

14 septembre 2022
Briefing

par Dr. Anja Lunze, LL.M.

Cliquer ici pour en savoir plus
UPC

Nullity proceedings in the UPC system

11 août 2022
Briefing

par plusieurs auteurs

Cliquer ici pour en savoir plus
Brevets et innovation

L'UPC avanza; brush up your Italian?

21 juillet 2022

par plusieurs auteurs

Cliquer ici pour en savoir plus
UPC

Preliminary Injunction before the UPC

13 juillet 2022
In-depth analysis

par plusieurs auteurs

Cliquer ici pour en savoir plus
Brevets et innovation

UPC and Unitary Patent fees

2 juin 2022
In-depth analysis

par plusieurs auteurs

Cliquer ici pour en savoir plus
Brevets et innovation

The “unitary effect” of the “European Patent with Unitary Effect”

13 mai 2022
Cliquer ici pour en savoir plus
UPC

Seven steps to UPC readiness

6 mai 2022
Briefing

par plusieurs auteurs

Cliquer ici pour en savoir plus
UPC

UPC opt-out: "Should I stay or should I go?"

6 avril 2022
Briefing

par Dr. Anja Lunze, LL.M. et Alina Krukover

Cliquer ici pour en savoir plus
Sciences de la vie et Santé

German Federal Patent Court invalidates Janumet SPC, refuses to refer questions to the CJEU

28 mars 2022
Briefing

par Dr. Nora E. Wessendorf, LL.M. (Washington)

Cliquer ici pour en savoir plus
UPC

Will the Unitary Patent be joined by a Unitary SPC right?

17 mars 2022
Quick read

par plusieurs auteurs

Cliquer ici pour en savoir plus

Related experts

Please contact one of our experts for more information about our capabilities and expertise. You can also search for a particular individual or see the whole team by using our people finder.